COVID-19 vaccinations Germany 2022, by manufacturer

As of 2022, the BioNTech vaccine against the coronavirus (COVID-19) was administered the most in Germany. Figures were significantly higher for BioNTech vaccinations, compared to the other vaccines approved for use in the EU – Moderna, AstraZeneca and Janssen. BioNTech is a German biotechnological company, which developed a vaccine against COVID-19 in cooperation with U.S. pharmaceutical giant Pfizer. New vaccines BioNTech and Moderna are mRNA vaccines, AstraZeneca is not, but all three have one thing in common – they have to be administered in two doses over a period of several weeks to provide protection against the virus. The Janssen vaccine, also referred to as Johnson & Johnson, referring to its manufacturer, requires one dose. Both BioNTech and Moderna vaccines have already been administered as booster shots while another coronavirus wave engulfs Germany. After initial shortages in deliveries at the beginning of Germany’s vaccination campaign at the end of December 2020, production has ramped up, also within the country, and the German government repeatedly assures the population that there are enough vaccines for first, second and booster shots.The next wave Thus far there is no national vaccination mandate in Germany, though heated debate among political parties regarding the issue continues, particularly in the wake of rising coronavirus cases in the winter of 2021 and the emergence of the Omicron variant. While all the currently greenlighted vaccines against COVID-19 are not said to make the recipient immune to the virus, they are widely hailed as helping reduce the risk of a difficult illness or the possibility of a hospital stay.

截至2022年，德国施用的BioNTech冠状病毒（COVID-19）疫苗数量最多。与欧盟批准的其他疫苗——Moderna、阿斯利康和杨森疫苗相比，BioNTech疫苗的使用数量显著更高。BioNTech是一家德国生物技术公司，与美国制药巨头辉瑞公司合作开发了针对COVID-19的疫苗。新的疫苗中，BioNTech和Moderna疫苗均为mRNA疫苗，而阿斯利康疫苗则不然，但三者共通之处在于——它们都需要在数周内分两次接种，以提供对病毒的防护。杨森疫苗，亦称为强生疫苗，以生产该疫苗的公司命名，仅需一剂。在德国疫苗接种活动于2020年12月底开始初期出现供应短缺之后，产量已提升，包括国内生产，德国政府多次向公众保证，有足够的疫苗用于首剂、第二剂和加强剂。接下来的浪潮。截至目前，德国尚未实施全国疫苗接种强制令，尽管关于此问题的政治党派间的热烈辩论仍在持续，尤其是在2021年冬季新冠病毒病例上升和奥密克戎变异株出现之后。尽管目前所有批准使用的COVID-19疫苗并未声称能使接种者对病毒产生免疫力，但它们被广泛赞誉有助于降低患重病或住院的可能性。